The utilization of psychopharmacological treatments for individuals with autism spectrum disorder (ASD) in a middle-income European country

Stojanovska, Irena, Chatterjee, Anirban, Syed, Yasir Ahmed ORCID: https://orcid.org/0000-0001-9495-307X and Trajkovski, Vladimir 2024. The utilization of psychopharmacological treatments for individuals with autism spectrum disorder (ASD) in a middle-income European country. Research in Autism Spectrum Disorders 111 , 102329. 10.1016/j.rasd.2024.102329

PDF - Published Version Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (2MB)

Abstract

Background: Studies examining the utilization of psychopharmacological treatments (psychotropic medications) for autism spectrum disorder (ASD) have primarily been carried out in affluent nations. Nonetheless, there is an evident dearth of data originating from low- and middle-income countries. Our study sought to comprehensively evaluate the usage of psychopharmacological treatments and the effectiveness of those treatments as perceived by the parents of individuals with autism spectrum disorder (ASD) in Macedonia, a middle-income country in South-Eastern Europe. Methods: We conducted a survey involving 103 parents of individuals with ASD and analyzed the questionnaire responses using descriptive statistics and non-parametric tests. Results: Our research uncovered that 62% of individuals diagnosed with ASD were prescribed psychopharmacological treatments, yet only 48% actually utilized them. Among the medications prescribed, antipsychotics (55%) and antiepileptics (44%) were the most common, with risperidone and valproate being the preferred options. Psychopharmacological treatments were found to be more commonly used among individuals aged 15 years and above, with children under 8 years closely following suit at a rate of 56%. Furthermore, we discovered a noteworthy association between the severity of ASD symptoms and the utilization of these interventions. Intriguingly, the majority of parents (73%) regarded the effectiveness of psychopharmacological treatments as only partially effective. Conclusion: Our study emphasizes the prevalent utilization of psychotropic medication, especially among young individuals, and underscores the necessity for enhanced dissemination of information to parents regarding prescribed medications. By integrating our research findings, medical professionals and policymakers can enhance the strategies and initiatives used to improve the quality of care and support for individuals on the autism spectrum.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Biosciences Neuroscience and Mental Health Research Institute (NMHRI)
Publisher:	Elsevier
ISSN:	1750-9467
Date of First Compliant Deposit:	8 January 2024
Date of Acceptance:	6 January 2024
Last Modified:	28 Feb 2024 12:08
URI:	https://orca.cardiff.ac.uk/id/eprint/165335

Actions (repository staff only)

Edit Item